ID   IF2B1_RAT               Reviewed;         577 AA.
AC   Q8CGX0; B1WBP3;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   24-JUL-2024, entry version 142.
DE   RecName: Full=Insulin-like growth factor 2 mRNA-binding protein 1;
DE            Short=IGF2 mRNA-binding protein 1;
DE            Short=IMP-1;
DE   AltName: Full=B-actin zipcode-binding protein 1;
DE            Short=ZBP1;
DE            Short=rZBP-1;
DE   AltName: Full=IGF-II mRNA-binding protein 1;
DE   AltName: Full=VICKZ family member 1;
GN   Name=Igf2bp1; Synonyms=Imp1, Vickz1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Embryonic brain;
RX   PubMed=14614102; DOI=10.1523/jneurosci.23-32-10433.2003;
RA   Eom T., Antar L.N., Singer R.H., Bassell G.J.;
RT   "Localization of a beta-actin messenger ribonucleoprotein complex with
RT   zipcode-binding protein modulates the density of dendritic filopodia and
RT   filopodial synapses.";
RL   J. Neurosci. 23:10433-10444(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryonic kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   RNA-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=9178888; DOI=10.1038/sj.onc.1201093;
RA   Leeds P., Kren B.T., Boylan J.M., Betz N.A., Steer C.J., Gruppuso P.A.,
RA   Ross J.;
RT   "Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes
RT   c-myc mRNA in vitro.";
RL   Oncogene 14:1279-1286(1997).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12716932; DOI=10.1523/jneurosci.23-08-03251.2003;
RA   Tiruchinapalli D.M., Oleynikov Y., Kelic S., Shenoy S.M., Hartley A.,
RA   Stanton P.K., Singer R.H., Bassell G.J.;
RT   "Activity-dependent trafficking and dynamic localization of zipcode binding
RT   protein 1 and beta-actin mRNA in dendrites and spines of hippocampal
RT   neurons.";
RL   J. Neurosci. 23:3251-3261(2003).
RN   [6]
RP   FUNCTION IN AXONAL REGENERATION.
RX   PubMed=21964071; DOI=10.1038/emboj.2011.347;
RA   Donnelly C.J., Willis D.E., Xu M., Tep C., Jiang C., Yoo S., Schanen N.C.,
RA   Kirn-Safran C.B., van Minnen J., English A., Yoon S.O., Bassell G.J.,
RA   Twiss J.L.;
RT   "Limited availability of ZBP1 restricts axonal mRNA localization and nerve
RT   regeneration capacity.";
RL   EMBO J. 30:4665-4677(2011).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   213-LYS-GLU-214; 294-LYS-GLU-295; TYR-396 AND 423-LYS-LYS-424.
RX   PubMed=21471362; DOI=10.1523/jneurosci.2387-10.2011;
RA   Perycz M., Urbanska A.S., Krawczyk P.S., Parobczak K., Jaworski J.;
RT   "Zipcode binding protein 1 regulates the development of dendritic arbors in
RT   hippocampal neurons.";
RL   J. Neurosci. 31:5271-5285(2011).
RN   [8]
RP   REVIEW.
RX   PubMed=23069990; DOI=10.1007/s00018-012-1186-z;
RA   Bell J.L., Wachter K., Muhleck B., Pazaitis N., Kohn M., Lederer M.,
RA   Huttelmaier S.;
RT   "Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-
RT   transcriptional drivers of cancer progression?";
RL   Cell. Mol. Life Sci. 70:2657-2675(2013).
CC   -!- FUNCTION: RNA-binding factor that recruits target transcripts to
CC       cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging'
CC       into mRNPs allows mRNA transport and transient storage. It also
CC       modulates the rate and location at which target transcripts encounter
CC       the translational apparatus and shields them from endonuclease attacks
CC       or microRNA-mediated degradation. Preferentially binds to N6-
CC       methyladenosine (m6A)-containing mRNAs and increases their stability
CC       (By similarity). During neuronal development, key regulator of neurite
CC       outgrowth, growth cone guidance and neuronal cell migration, presumably
CC       through the spatiotemporal fine tuning of protein synthesis, such as
CC       that of beta-actin/ACTB (By similarity). May regulate mRNA transport to
CC       activated synapses (By similarity). Binds to the 3'-UTR of CD44 mRNA
CC       and stabilizes it, hence promotes cell adhesion and invadopodia
CC       formation in cancer cells (By similarity). Binds to the oncofetal H19
CC       transcript and to the neuron-specific TAU mRNA and regulates their
CC       localization (By similarity). Binds to and stabilizes BTRC/FBW1A mRNA
CC       (By similarity). Binds to the adenine-rich autoregulatory sequence
CC       (ARS) located in PABPC1 mRNA and represses its translation. PABPC1
CC       mRNA-binding is stimulated by PABPC1 protein. Prevents BTRC/FBW1A mRNA
CC       degradation by disrupting microRNA-dependent interaction with AGO2 (By
CC       similarity). During cellular stress, such as oxidative stress or heat
CC       shock, stabilizes target mRNAs that are recruited to stress granules,
CC       including CD44, IGF2, MAPK4, MYC, PTEN, RAPGEF2 and RPS6KA5 transcripts
CC       (By similarity). Binds to the 3'-UTR of IGF2 mRNA by a mechanism of
CC       cooperative and sequential dimerization and regulates IGF2 mRNA
CC       subcellular localization and translation. Binds to MYC mRNA, in the
CC       coding region instability determinant (CRD) of the open reading frame
CC       (ORF), hence prevents MYC cleavage by endonucleases and possibly
CC       microRNA targeting to MYC-CRD (By similarity). Binding to MYC mRNA is
CC       enhanced by m6A-modification of the CRD (By similarity). Binds to and
CC       stabilizes ABCB1/MDR-1 mRNA (By similarity). During interstinal wound
CC       repair, interacts with and stabilizes PTGS2 transcript. PTGS2 mRNA
CC       stabilization may be crucial for colonic mucosal wound healing (By
CC       similarity). Interacts with GAP43 transcript and transports it to
CC       axons. Regulates localized ACTB mRNA translation, a crucial process for
CC       cell polarity, cell migration and neurite outgrowth. Co-
CC       transcriptionally associates with the ACTB mRNA in the nucleus. This
CC       binding involves a conserved 54-nucleotide element in the ACTB mRNA 3'-
CC       UTR, known as the 'zipcode'. The RNP thus formed is exported to the
CC       cytoplasm, binds to a motor protein and is transported along the
CC       cytoskeleton to the cell periphery. During transport, prevents ACTB
CC       mRNA from being translated into protein. When the RNP complex reaches
CC       its destination near the plasma membrane, IGF2BP1 is phosphorylated.
CC       This releases the mRNA, allowing ribosomal 40S and 60S subunits to
CC       assemble and initiate ACTB protein synthesis. Monomeric ACTB then
CC       assembles into the subcortical actin cytoskeleton. Plays a direct role
CC       in the transport and translation of transcripts required for axonal
CC       regeneration in adult sensory neurons. {ECO:0000250|UniProtKB:Q9NZI8,
CC       ECO:0000269|PubMed:12716932, ECO:0000269|PubMed:14614102,
CC       ECO:0000269|PubMed:21471362, ECO:0000269|PubMed:21964071}.
CC   -!- SUBUNIT: Can form homodimers and heterodimers with IGF2BP1 and IGF2BP3
CC       (By similarity). Component of the coding region determinant (CRD)-
CC       mediated complex, composed of DHX9, HNRNPU, IGF2BP1, SYNCRIP and YBX1
CC       (By similarity). Identification in a mRNP complex, at least composed of
CC       DHX9, DDX3X, ELAVL1, HNRNPU, IGF2BP1, ILF3, PABPC1, PCBP2, PTBP2,
CC       STAU1, STAU2, SYNCRIP and YBX1 (By similarity). Associates with mRNP
CC       complex (By similarity). Interacts with FMR1 (By similarity). Component
CC       of a multisubunit autoregulatory ribonucleoprotein complex (ARC), at
CC       least composed of IGF2BP1, PABPC1 and CSDE1 (By similarity). Interacts
CC       through the third and fourth KH domains with PABPC1 in an RNA-
CC       independent manner (By similarity). Component of a TAU mRNP complex, at
CC       least composed of IGF2BP1, ELAVL4 and G3BP (By similarity). Interacts
CC       with ELAVL4 in an RNA-dependent manner (By similarity). Associates with
CC       microtubules and polysomes. Interacts with AGO1 and AGO2 (By
CC       similarity). Interacts with ELAVL1 and MATR3 (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NZI8}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm. Cytoplasm,
CC       perinuclear region {ECO:0000250}. Cytoplasm, P-body
CC       {ECO:0000250|UniProtKB:Q9NZI8}. Cytoplasm, Stress granule
CC       {ECO:0000250|UniProtKB:Q9NZI8}. Cell projection, lamellipodium
CC       {ECO:0000250}. Cell projection, dendrite. Cell projection, dendritic
CC       spine. Cell projection, growth cone {ECO:0000250}. Cell projection,
CC       filopodium. Cell projection, axon. Note=In the nucleus, located in
CC       discrete foci, coinciding with the sites of ACTB transcription (By
CC       similarity). In the cytoplasm, localizes in cytoplasmic mRNP granules.
CC       Colocalizes with microtubules in growth cone filopodia and along
CC       neurites in neuronal cells (By similarity). Cytoplasmic colocalization
CC       with ACTB mRNA is partially lost at the cell periphery, suggesting
CC       release of the transcript (By similarity). In cultured hippocampal
CC       neurons, predominantly located within dendrites, particularly at
CC       dendritic branching points in young cells, compared to axons. In axons,
CC       predominantly found in axonal branches and their growth cones. In
CC       dendrites, can exhibit different types of movements, from fast
CC       retrograde and anterograde movements to stable localization. Dendritic
CC       levels are regulated by neuronal activity and glutaminergic signals:
CC       they are increased by KCl-induced depolarization, which induces rapid
CC       efflux from the cell body into dendrites, and decreased by the NMDA
CC       receptor agonist AP-5. In motile cells, such as migrating fibroblasts,
CC       localizes to leading edges where it colocalizes with microtubules and
CC       microfilaments and to retracting tails (By similarity). In motile
CC       cells, transported towards the leading edge into the cortical region of
CC       the lamellipodia where it is connected to microfilaments (By
CC       similarity). In response to cellular stress, such as oxidative stress
CC       or heat shock, recruited to stress granules, but not to processing
CC       bodies (By similarity). {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in fetal development and neonatal life,
CC       but is undetectable in adult tissues (at protein level). Expressed in
CC       embryonic neurons, including in hippocampal (at protein level) and
CC       cortical neurons. Also expressed in transformed tissue cultured cell
CC       lines derived form adult tissues (at protein level).
CC       {ECO:0000269|PubMed:12716932, ECO:0000269|PubMed:14614102,
CC       ECO:0000269|PubMed:21471362, ECO:0000269|PubMed:9178888}.
CC   -!- DOMAIN: Domains KH3 and KH4 are the major RNA-binding modules, although
CC       KH1 and KH2 may also contribute. KH1 and KH2, and possibly KH3 and KH4,
CC       promote the formation of higher ordered protein-RNA complexes, which
CC       may be essential for IGF2BP1 cytoplasmic retention. KH domains are
CC       required for RNA-dependent homo- and heterooligomerization and for
CC       localization to stress granules. KH3 and KH4 mediate association with
CC       the cytoskeleton. Two nuclear export signals (NES) have been identified
CC       in KH2 and KH4 domains, respectively. Only KH2 NES is XPO1-dependent.
CC       Both NES may be redundant, since individual in vitro mutations do not
CC       affect subcellular location of the full-length protein (By similarity).
CC       {ECO:0000250|UniProtKB:Q9NZI8}.
CC   -!- PTM: Phosphorylated. Phosphorylation may impair association with ACTB
CC       mRNA and hence abolishes translational repression (By similarity).
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the RRM IMP/VICKZ family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF541940; AAO16210.1; -; mRNA.
DR   EMBL; CH473948; EDM05776.1; -; Genomic_DNA.
DR   EMBL; BC161831; AAI61831.1; -; mRNA.
DR   RefSeq; NP_783184.1; NM_175594.2.
DR   AlphaFoldDB; Q8CGX0; -.
DR   SMR; Q8CGX0; -.
DR   BioGRID; 257545; 4.
DR   STRING; 10116.ENSRNOP00000008139; -.
DR   iPTMnet; Q8CGX0; -.
DR   PhosphoSitePlus; Q8CGX0; -.
DR   PaxDb; 10116-ENSRNOP00000008139; -.
DR   Ensembl; ENSRNOT00000008139.6; ENSRNOP00000008139.3; ENSRNOG00000006122.6.
DR   Ensembl; ENSRNOT00055056466; ENSRNOP00055046572; ENSRNOG00055032679.
DR   Ensembl; ENSRNOT00060044288; ENSRNOP00060036725; ENSRNOG00060025575.
DR   Ensembl; ENSRNOT00065029916; ENSRNOP00065023761; ENSRNOG00065017872.
DR   GeneID; 303477; -.
DR   KEGG; rno:303477; -.
DR   UCSC; RGD:708580; rat.
DR   AGR; RGD:708580; -.
DR   CTD; 10642; -.
DR   RGD; 708580; Igf2bp1.
DR   eggNOG; KOG2193; Eukaryota.
DR   GeneTree; ENSGT00940000160427; -.
DR   HOGENOM; CLU_020744_1_0_1; -.
DR   InParanoid; Q8CGX0; -.
DR   OMA; YIPDEQT; -.
DR   OrthoDB; 3035007at2759; -.
DR   PhylomeDB; Q8CGX0; -.
DR   TreeFam; TF320229; -.
DR   PRO; PR:Q8CGX0; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Proteomes; UP000234681; Chromosome 10.
DR   Bgee; ENSRNOG00000006122; Expressed in stomach and 1 other cell type or tissue.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0070937; C:CRD-mediated mRNA stability complex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0010494; C:cytoplasmic stress granule; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0030175; C:filopodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000932; C:P-body; ISS:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISS:UniProtKB.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IDA:RGD.
DR   GO; GO:0048027; F:mRNA 5'-UTR binding; ISO:RGD.
DR   GO; GO:0003729; F:mRNA binding; ISS:UniProtKB.
DR   GO; GO:1990247; F:N6-methyladenosine-containing RNA reader activity; ISS:UniProtKB.
DR   GO; GO:0045182; F:translation regulator activity; ISO:RGD.
DR   GO; GO:0070934; P:CRD-mediated mRNA stabilization; ISS:UniProtKB.
DR   GO; GO:0140059; P:dendrite arborization; IMP:RGD.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:1900152; P:negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; ISO:RGD.
DR   GO; GO:0017148; P:negative regulation of translation; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISO:RGD.
DR   GO; GO:0022013; P:pallium cell proliferation in forebrain; ISO:RGD.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; ISO:RGD.
DR   GO; GO:0010610; P:regulation of mRNA stability involved in response to stress; ISS:UniProtKB.
DR   GO; GO:0006403; P:RNA localization; IMP:RGD.
DR   CDD; cd22490; KH-I_IGF2BP1_rpt1; 1.
DR   CDD; cd22493; KH-I_IGF2BP1_rpt2; 1.
DR   CDD; cd22496; KH-I_IGF2BP1_rpt3; 1.
DR   CDD; cd22499; KH-I_IGF2BP1_rpt4; 1.
DR   CDD; cd12625; RRM1_IGF2BP1; 1.
DR   CDD; cd12628; RRM2_IGF2BP1; 1.
DR   Gene3D; 3.30.310.210; -; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   Gene3D; 3.30.1370.10; K Homology domain, type 1; 2.
DR   InterPro; IPR034837; IGF2BP1_RRM1.
DR   InterPro; IPR034842; IGF2BP1_RRM2.
DR   InterPro; IPR004087; KH_dom.
DR   InterPro; IPR004088; KH_dom_type_1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   PANTHER; PTHR10288:SF92; INSULIN-LIKE GROWTH FACTOR 2 MRNA-BINDING PROTEIN 1; 1.
DR   PANTHER; PTHR10288; KH DOMAIN CONTAINING RNA BINDING PROTEIN; 1.
DR   Pfam; PF00013; KH_1; 4.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00322; KH; 4.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54791; Eukaryotic type KH-domain (KH-domain type I); 4.
DR   SUPFAM; SSF54928; RNA-binding domain, RBD; 1.
DR   PROSITE; PS50084; KH_TYPE_1; 4.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   Cell projection; Cytoplasm; mRNA transport; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; RNA-binding; Synapse; Translation regulation;
KW   Transport.
FT   CHAIN           1..577
FT                   /note="Insulin-like growth factor 2 mRNA-binding protein 1"
FT                   /id="PRO_0000282535"
FT   DOMAIN          2..75
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          81..156
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          195..260
FT                   /note="KH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          276..343
FT                   /note="KH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          405..470
FT                   /note="KH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   DOMAIN          487..553
FT                   /note="KH 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00117"
FT   REGION          160..190
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          187..570
FT                   /note="Necessary for interaction with ELAVL4 and binding to
FT                   TAU mRNA"
FT                   /evidence="ECO:0000250"
FT   REGION          312..323
FT                   /note="Sufficient for nuclear export"
FT                   /evidence="ECO:0000250"
FT   REGION          485..495
FT                   /note="Sufficient for nuclear export"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         12
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZI8"
FT   MOD_RES         73
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZI8"
FT   MOD_RES         181
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZI8"
FT   MOD_RES         528
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9NZI8"
FT   MUTAGEN         213..214
FT                   /note="KE->EL: Loss of function in dendritogenesis; when
FT                   associated with 294-E-L-295 and 423-E-L-424."
FT                   /evidence="ECO:0000269|PubMed:21471362"
FT   MUTAGEN         294..295
FT                   /note="KE->EL: Loss of function in dendritogenesis; when
FT                   associated with 213-E-L-214 and 423-E-L-424."
FT                   /evidence="ECO:0000269|PubMed:21471362"
FT   MUTAGEN         396
FT                   /note="Y->F: Loss of function in dendritogenesis."
FT                   /evidence="ECO:0000269|PubMed:21471362"
FT   MUTAGEN         423..424
FT                   /note="KK->EL: Loss of function in dendritogenesis; when
FT                   associated with 213-E-L-214 and 294-E-L-295."
FT                   /evidence="ECO:0000269|PubMed:21471362"
SQ   SEQUENCE   577 AA;  63437 MW;  0647676128FBD1EE CRC64;
     MNKLYIGNLN ESVTPADLEK VFAEHKISYS GQFLVKSGYA FVDCPDEHWA MKAIETFSGK
     VELQGKRLEI EHSVPKKQRS RKIQIRNIPP QLRWEVLDSL LAQYGTVENC EQVNTESETA
     VVNVTYSNRE QTRQAIMKLN GHQLENHALK VSYIPDEQIA QGPENGRRGG FGSRGQPRQG
     SPVAAGAPAK QQQVDIPLRL LVPTQYVGAI IGKEGATIRN ITKQTQSKID VHRKENAGAA
     EKAISVHSTP EGCSSACKMI LEIMHKEAKD TKTADEVPLK ILAHNNFVGR LIGKEGRNLK
     KVEQDTETKI TISSLQDLTL YNPERTITVK GAIENCCRAE QEIMKKVREA YENDVAAMSL
     QSHLIPGLNL AAVGLFPASS SAVPPPPSSV TGAAPYGSFM QAPEQEMVQV FIPAQAVGAI
     IGKKGQHIKQ LSRFASASIK IAPPETPDSK VRMVVITGPP EAQFKAQGRI YGKLKEENFF
     GPKEEVKLET HIRVPASAAG RVIGKGGKTV NELQNLTAAE VVVPRDQTPD ENDQVIVKII
     GHFYASQMAQ RKIRDILAQV KQQHQKGQSN QAQARRK
//
